Abbott Laboratories
์๊ฐ์ด์ก
$196.3B
๊ธ๋ก๋ฒ ์์
#79
์ญ๋ ์ต๊ณ ์น
$224.9B
2021-12-31
์ด ์ฑ์ฅ๋ฅ
+0%
2026๋ ์ดํ
Market Cap Context
- Larger than 78% of the 367 companies we track (globally).
- Equivalent to 0.6% of United States's GDP (2025 data).
- Just above: #78 Amphenol Corporation ($196.7B)
- Just below: #80 T-Mobile US, Inc. ($196.0B)
- Best year: 2017 (+52%). Worst year: 2002 (-27%).
Abbott Laboratories Financial Breakdown (FY 2025)
Source: Yahoo Finance โ ABT annual filings (2025) โ$44.3B revenue ยท $8.1B operating income ยท $6.5B net income
- โOperating margin: 18.2% on $44.3B in revenue.
- โR&D is 6.6% of revenue ($2.9B).
- โNet income margin: 14.7% โ $6.5B in profit.
- โFree cash flow: $7.4B (16.7% of revenue).
Cost / Operating Expenses
Total operating expenses $36.3B
Total
$34.6B
Capital Expenditures
$2.2B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$7.4B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Abbott Laboratories ์๊ฐ
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company founded in Chicago with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.
Abbott Laboratories ์๊ฐ์ด์ก ์ถ์ด (2026โ2026)
Abbott Laboratories vs Sector Peers by Market Cap
Abbott Laboratories ๋น๊ต
์์ ์ถ์ด
| ์ฐ๋ | ์๊ฐ์ด์ก | ์์ | ์ ๋ ๋๋น ๋ณํ |
|---|---|---|---|
| 2026 | $196.3B | #79(โ19) | -9.0% |
| 2025 | $215.8B | #60(โ6) | +12.9% |
| 2024 | $191.2B | #54(โ1) | +4.8% |
| 2023 | $182.4B | #53(โ10) | +2.3% |
| 2022 | $178.4B | #43(โ4) | -20.7% |
| 2021 | $224.9B | #39(โ2) | +30.5% |
| 2020 | $172.3B | #37(โ6) | +28.0% |
| 2019 | $134.6B | #43 | +22.1% |
| 2018 | $110.2B | #43(โ12) | +29.1% |
| 2017 | $85.4B | #55(โ20) | +52.0% |
| 2016 | $56.2B | #75(โ17) | -12.3% |
| 2015 | $64.1B | #58(โ2) | +1.9% |
| 2014 | $62.9B | #56(โ3) | +20.1% |
| 2013 | $52.4B | #59(โ1) | +24.0% |
| 2012 | $42.2B | #60(โ2) | +20.3% |
| 2011 | $35.1B | #58(โ13) | +21.8% |
| 2010 | $28.8B | #71(โ11) | -8.3% |
| 2009 | $31.4B | #60(โ17) | +4.6% |
| 2008 | $30.1B | #43(โ27) | -2.5% |
| 2007 | $30.8B | #70(โ3) | +18.0% |
| 2006 | $26.1B | #67(โ9) | +26.9% |
| 2005 | $20.6B | #76(โ18) | -13.5% |
| 2004 | $23.8B | #58(โ2) | +17.8% |
| 2003 | $20.2B | #60(โ10) | +19.3% |
| 2002 | $16.9B | #50(โ5) | -26.7% |
| 2001 | $23.1B | #55(โ11) | +17.1% |
| 2000 | $19.7B | #66(โ2) | +35.8% |
| 1999 | $14.5B | #64(โ21) | -24.8% |
| 1998 | $19.3B | #43 | +51.8% |
| 1997 | $12.7B | #43(โ2) | +32.0% |
| 1996 | $9.6B | #45(โ3) | +24.6% |
| 1995 | $7.7B | #42(โ6) | +30.5% |
| 1994 | $5.9B | #36 |
๊ธฐํ ํฌ์ค์ผ์ด ๊ธฐ์
์์ฃผ ๋ฌป๋ ์ง๋ฌธ
What is Abbott Laboratories's market cap?
Abbott Laboratories (ABT) has a market capitalization of $196.3B, making it the #79 largest company in the world by market cap.
What was Abbott Laboratories's highest market cap?
Abbott Laboratories's all-time high market cap was $224.9B, reached in 2021-12-31. Its highest rank was #39 in 2021.
What sector is Abbott Laboratories in?
Abbott Laboratories is in the Healthcare sector, specifically the Medical Devices industry. It is based in United States.
How has Abbott Laboratories's market cap changed over time?
Abbott Laboratories has been tracked since 2026. Its market cap has grown by 0% from $196.3B in 2026 to $196.3B today.